Cargando…
Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital
BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to be a significant health problem worldwide. The unprecedented surge of mucormycosis in patients with COVID-19 is a new emerging challenge. Although a few studies documenting high incidence of mucormycosis in COVID -19 patients have recently...
Autores principales: | Kumari, Abha, Rao, Nusumu Purnachandra, Patnaik, Uma, Malik, Virender, Tevatia, Manvir Singh, Thakur, Shivali, Jaydevan, Jijesh, Saxena, Pavitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313063/ https://www.ncbi.nlm.nih.gov/pubmed/34334896 http://dx.doi.org/10.1016/j.mjafi.2021.06.009 |
Ejemplares similares
-
Varied presentations of complicated rhinosinusitis in COVID era: a rational approach to management
por: Thakur, Shivali, et al.
Publicado: (2023) -
Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity
por: Jain, Ashish, et al.
Publicado: (2022) -
Isolated CNS Relapse in Acute Lymphoblastic Leukemia (ALL): An Experience from a Tertiary Care Center
por: Tevatia, Manvir Singh, et al.
Publicado: (2021) -
Primary Breast Tumors with Mesenchymal Morphology
por: Tevatia, Manvir S., et al.
Publicado: (2021) -
Are vitamin D, B12, and folate deficiency associated with depressive disorder? A case-control study
por: Bharti, Abhishek, et al.
Publicado: (2023)